The Centre, P.C. - Plastic Surgery Blog

Radiesse Gets Validation in Clinical Studies - Tuesday, July 08, 2008

At The Centre, P.C, we have long been offering Radiesse injections for our patients, and now we are happy to see that clinical studies have recently provided more evidence of its safety and effectiveness.

Radiesse is the first approved "composite" injectable. Composite injectables are formed using two very different components. A carrier gel allows a smooth injection of microspheres that last long after the carrier gel is absorbed by the body. As long as the microspheres are in place, the body fills in around them with collagen, leading to long-lasting results. In Radiesse, the carrier gel is methylcellulose, used in many other applications, including as a food thickener, and the microspheres are made of calcium hydroxylapatite, a compound commonly used as a bone filler.

Now a battery of studies published in the June 2008 issue of the Journal of Dermatologic Study has provided more evidence that the results of Radiesse last much longer than non-composite injectables currently on the market. In one study, at least 80 % of 1000 patients were shown to have continued results one year after treatment without retreatment, making the results much longer than injectables like Restylane or Juvéderm. In two different studies, one using a histologic model and the other using a canine host, it was shown that Radiesse did stimulate the body to produce collagen around the microspheres.

These studies show that Radiesse remains one of the longest-lasting solutions to facial voids and wrinkles. To learn more about facial fillers and their results, contact The Centre, P.C. today to set up a consultation.